Arturo Cesaro: First Meta-Analysis on the Vascular Protective Role of Semaglutide in PAD
Arturo Cesaro, Assistant Professor of Cardiology at University of Campania “Luigi Vanvitelli”, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Just published in European Journal of Preventive Cardiology
Proud to share our newly published systematic review and meta-analysis evaluating the impact of semaglutide on peripheral artery disease (PAD)-related outcomes.
First meta-analysis focusing on PAD as a hard endpoint across randomized trials
Key takeaways
- Semaglutide was associated with a significant reduction in limb events
- Findings support a potential vascular protective role beyond coronary disease, extending to the peripheral circulation
A step forward in extending cardiometabolic prevention beyond the coronary circulation.
Huge thanks to all co-authors and collaborators for an outstandingy team effort.”
Title: Impact of semaglutide on limb events: a meta-analysis of randomized controlled trials
Authors: Arturo Cesaro, Vincenzo Acerbo, Miriam Longo, Alessandra Antonucci, Maria Ida Maiorino, Maria Grazia Monaco, Eugenio Martelli, Giorgio Giudice, Katherine Esposito, Francesco Giorgino, Massimo Federici, Paolo Calabrò
Read the Full Article on European Journal of Preventive Cardiology
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 30, 2026, 18:19Deva Nanda TK: A Practical Overview of Dural Sinuses and The Venous Drainage of the Brain
-
Apr 30, 2026, 18:08Amrit Kaur Kaler: The Hidden Genetic Drivers of Thrombosis
-
Apr 30, 2026, 18:06Alejandro González Veliz: The Most Dangerous Mistake After Getting a Stent
-
Apr 30, 2026, 18:03Carmen Ruiz: First Arterial Mechanical Thrombectomy in New Zealand Using the ARTIX System
-
Apr 30, 2026, 17:52Simon Senanu: von Willebrand Disease May Be Missed Despite Normal Tests
-
Apr 30, 2026, 17:20José Antonio García Erce: Why Healthy Older Adults Should Keep Donating Blood?
-
Apr 30, 2026, 17:13Paul Logan: Decoding the Words ‘He’s on blood thinners’
-
Apr 30, 2026, 17:01Jason Andrade: A Decade-Long Quest Proves Early Ablation Halves Persistent AF Burden
-
Apr 30, 2026, 16:56Oliver Maracic: Could Co-Targeting ALK with FAK/PYK2 Help Mitigate the High VTE Burden Seen in ALK with NSCLC